Clinical trial · Observational
Financial Toxicity in Breast Cancer Surgery
Financial Toxicity in Surgical Breast Cancer Patients: A Prospective, Multicenter Cohort Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to evaluate financial toxicity, or financial harm, in breast cancer patients. The study will follow patients throughout their cancer treatment. The study investigators will measure if patients are experiencing financial toxicity and if it changes throughout treatment, and whether it's associated with different cancers, treatments, or demographics. Also, the study investigators will measure if financial toxicity impacts other areas of life (e.g., well-being, satisfaction). Finally, patients will be asked to estimate how much money they expect to spend on out-of-pocket expenses during their treatment and how their finances and employment status have changed since their cancer diagnosis.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (3)
- label
- Breast conserving surgery only
- description
- Patients who receive breast conserving surgery.
- label
- Mastectomy only
- description
- Patients who receive mastectomy surgery.
- label
- Mastectomy & breast reconstruction
- description
- Patients who receive mastectomy and breast reconstruction.
Primary outcomes (1)
- measure
- Financial Toxicity (FT)
- timeFrame
- 12 months
- description
- FT will be assessed using the COmprehensive Score for financial Toxicity (COST). The COST measure is an 11-item cancer-specific patient-reported outcome measure. Each item is scored on a 0 to 4-point Likert scale, where a lower total score represents greater financial distress.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Female * Have an indication for surgical treatment of breast cancer * 18 years of age or older * Able to understand and communicate in English * Have access to email and internet and are able to fill out an electronic survey Exclusion Criteria: \- Patients will be excluded if they have recurrent or metastatic disease
References
Publications (0)
Data not yet available